Stocks and Investing Stocks and Investing
Mon, April 19, 2021

Matthew Harrison Maintained (BLUE) at Hold with Decreased Target to $36 on, Apr 19th, 2021


Published on 2024-10-27 16:17:09 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "bluebird bio, Inc." (BLUE) at Hold with Decreased Target from $45 to $36 on, Apr 19th, 2021.

Matthew has made no other calls on BLUE in the last 4 months.



There are 3 other peers that have a rating on BLUE. Out of the 3 peers that are also analyzing BLUE, 1 agrees with Matthew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Cory Kasimov of "JP Morgan" Downgraded from Buy to Hold and Decreased Target to $39 on, Wednesday, February 17th, 2021


These are the ratings of the 2 analyists that currently disagree with Matthew


  • Mani Foroohar of "SVB Leerink" Maintained at Buy with Increased Target to $72 on, Monday, March 29th, 2021
  • Difei Yang of "Mizuho" Upgraded from Hold to Strong Buy and Increased Target to $69 on, Wednesday, March 10th, 2021
Contributing Sources